InsiderClue
← All stocks

Cocrystal Pharma, Inc.

COCP Net buying
CIK 0001412486 #5004 in the set updated 18 Sep 2026
Bought (12 mo)
$300.21K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$300.21K
+$300.21K against sales at will

By person

8 insiders · 11 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
FROST PHILLIP MD ET AL
Director
$300.21K (11)
—
+$300.21K
2,020,651
10.49%
$1.98M
+53.1%
Rubin Steven D
Director
—
—
—
2,660,242
13.81%
$2.61M
+0.7%
Hassan Fred
Director
—
—
—
1,383,009
7.18%
$1.36M
+36.2%
Lee Sam
President and Co-CEO
—
—
—
76,355
0.3964%
$74.95K
+110.0%
Martin James Joseph
Co-CEO and CFO
—
—
—
44,167
0.2293%
$43.35K
+7,662%
PFENNIGER RICHARD C JR
Director
—
—
—
31,400
0.1630%
$30.82K
+842.1%
Kornberg Roger D.
Director
—
—
—
28,109
0.1459%
$27.59K
—
Japour Anthony J
Director
—
—
—
14,924
0.0775%
$14.65K
—

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
FROST PHILLIP MD ET AL
5 Aug 2026
Director
Buy indirect
10,000
$0.98
$9.82K
FROST PHILLIP MD ET AL
3 Aug 2026
Director
Buy indirect
75,000
$0.94
$70.59K
FROST PHILLIP MD ET AL
24 Feb 2026
Director
Buy indirect
20,000
$1.00
$19.95K
FROST PHILLIP MD ET AL
6 Feb 2026
Director
Buy indirect
50,000
$0.95
$47.28K
FROST PHILLIP MD ET AL
31 Dec 2025
Director
Buy indirect
50,000
$0.95
$47.28K
FROST PHILLIP MD ET AL
30 Dec 2025
Director
Buy indirect
20,000
$0.97
$19.31K
FROST PHILLIP MD ET AL
26 Dec 2025
Director
Buy indirect
40,000
$0.97
$38.94K
FROST PHILLIP MD ET AL
24 Dec 2025
Director
Buy indirect
25,000
$0.97
$24.26K
FROST PHILLIP MD ET AL
26 Nov 2025
Director
Buy indirect
2,500
$0.99
$2.48K
FROST PHILLIP MD ET AL
26 Nov 2025
Director
Buy indirect
1,500
$1.00
$1.50K
FROST PHILLIP MD ET AL
25 Nov 2025
Director
Buy indirect
20,000
$0.94
$18.81K

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 743,024
History held since 6 Sep 2016